RVL Pharmaceuticals plc Quarterly Earnings Per Share, Basic in USD/shares from Q2 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
RVL Pharmaceuticals plc quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2020 to Q2 2023.
  • RVL Pharmaceuticals plc Earnings Per Share, Basic for the quarter ending June 30, 2023 was -0.24 USD/shares, a 71.4% decline year-over-year.
  • RVL Pharmaceuticals plc Earnings Per Share, Basic for the twelve months ending June 30, 2023 was -0.72 USD/shares, a 4% increase year-over-year.
  • RVL Pharmaceuticals plc annual Earnings Per Share, Basic for 2022 was -0.58 USD/shares, a 39.6% increase from 2021.
  • RVL Pharmaceuticals plc annual Earnings Per Share, Basic for 2021 was -0.96 USD/shares, a 26.7% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$1 $0 $0 -71.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$1 $0 $0 -50% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$1 $0 +$0.05 +20% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-20
Q3 2022 -$1 $0 +$0.12 +42.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$1 $0 +$0.14 +50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1 $0 +$0.07 +46.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$1 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $0 $0 -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 $0 -27.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.